Closing soonInfectious diseases
Closes in 6 daysCenters for Disease Control - NCEZID · CDC-RFA-CK-26-0230
This Notice of Funding Opportunity (NOFO) aims to support activities that build and strengthen sustainable fungal disease detection, diagnosis, surveillance, and response systems. Activities may address interconnected areas such as system and workforce development, laboratory…
Biomarkers & diagnosticsTraining & career development
$15M totalDue Sep 30, 2026
Closing soonScience & R&D
Closes in 6 daysU.S. National Science Foundation · PD-20-1281
The Analysis Program supports research in analysis. Areas of current activity include complex, harmonic, and real analysis; dynamical systems and ergodic theory; functional analysis; mathematical physics; operator theory and operator algebras; partial differential equations and…
Amount not listedDue Sep 30, 2026
Closing soonScience & R&D
Closes in 6 daysDARPA - Biological Technologies Office · HR001126S0003
The Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office (BTO) is soliciting proposals that leverage biological properties and processes to revolutionize our ability to protect the nation’s warfighters. Specifically excluded is research that primarily…
Amount not listedDue Sep 30, 2026
Closing soonScience & R&DEnergyEnvironment
Closes in 6 daysFAA-COE-AJFE · FAA-COE-AJFE
The opportunity for the Federal Aviation Administration (FAA) Center of Excellence for Alternative Jet Fuel and Environment (AJFE) was awarded in 2013 to the ASCENT cooperative aviation research organization. ASCENT is a coalition of 16 leading US research universities committed…
$1 – $20MDue Sep 30, 2026
Closing soonHealthU54Clinical trial: Not allowed
Closes in 6 daysNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · RFA-DK-27-127
The purpose of this Notice of Funding Opportunity (NOFO) is to invite applications for Centers within the NIDDK Cooperative Centers of Experimental in Hematology (CCEH) Program. Each Center will support one to three Biomedical Research Cores and an Administrative Core, including…
Data & infrastructure
$3.7M totalDue Sep 30, 2026
Closing soonBasic science (physics, chemistry, math)
Closes in 6 daysU.S. National Science Foundation · 22-605
This solicitation applies to six (of the nine) CHE Disciplinary Research Programs: Chemical Catalysis (CAT); Chemical Measurement and Imaging (CMI); Chemical Mechanism, Function and Properties (CMFP); Chemical Synthesis (SYN); Environmental Chemical Sciences (ECS); and…
Basic mechanisms & biologyBiomarkers & diagnosticsTraining & career development
$105M totalDue Sep 30, 2026
Closing soonNeurological disorders (other)
Closes in 6 daysDept. of Defense — CDMRP · HT942526ALSRPCOBA
Summary: The fiscal year 2026 (FY26) Amyotrophic Lateral Sclerosis Research Program (ALSRP) Clinical Outcomes and Biomarkers Award (COBA) supports the development and/or validation of clinical outcomes and biomarkers to enrich clinical trials in amyotrophic lateral sclerosis…
Biomarkers & diagnosticsTherapeutics & drug discoveryClinical trials
$7M totalDue Sep 30, 2026
Closing soonNeurological disorders (other)
Closes in 6 daysDept. of Defense — CDMRP · HT942526ALSRPPCTA
Summary: The fiscal year 2026 (FY26) Amyotrophic Lateral Sclerosis Research Program (ALSRP) Pilot Clinical Trial Award (PCTA) supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of amyotrophic…
Basic mechanisms & biologyBiomarkers & diagnosticsTherapeutics & drug discoveryClinical trials
$5.6M totalDue Sep 30, 2026
Closing soonNeurological disorders (other)
Closes in 6 daysDept. of Defense — CDMRP · HT942526ALSRPTDA
Summary: The fiscal year 2026 (FY26) Amyotrophic Lateral Sclerosis Research Program (ALSRP) Therapeutic Development Award (TDA) supports research ranging from preclinical validation of therapeutic leads through U.S. Food and Drug Administration (FDA) Investigational New Drug…
Basic mechanisms & biologyBiomarkers & diagnosticsTherapeutics & drug discoveryData & infrastructure
$12M totalDue Sep 30, 2026
Closing soonNeurological disorders (other)
Closes in 6 daysDept. of Defense — CDMRP · HT942526ALSRPTIA
Summary: The fiscal year 2026 (FY26) Amyotrophic Lateral Sclerosis Research Program (ALSRP) Therapeutic Idea Award (TIA) supports new, innovative, high-risk, high-gain ideas aimed at amyotrophic lateral sclerosis (ALS) drug or therapy discovery. The studies supported by this…
Basic mechanisms & biologyTherapeutics & drug discovery
$10.1M totalDue Sep 30, 2026
Closing soonCancer & oncology
Closes in 6 daysDept. of Defense — CDMRP · HT942526BCRPBTA3
Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Breakthrough Award mechanism supports promising research with high potential to lead to or make breakthroughs in breast cancer. All applications must address at least one of the FY26 BCRP overarching…
Basic mechanisms & biologyClinical trials
$12.6M totalDue Sep 30, 2026
Closing soonCancer & oncology
Closes in 6 daysDept. of Defense — CDMRP · HT942526BCRPBTA4
Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Breakthrough Award mechanism supports promising research with high potential to lead to or make breakthroughs in breast cancer. All applications must address at least one of the FY26 BCRP overarching…
Basic mechanisms & biologyClinical trials
$21M totalDue Sep 30, 2026
Closing soonCancer & oncology
Closes in 6 daysDept. of Defense — CDMRP · HT942526BCRPTBCCA
Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Transformative Breast Cancer Consortium Award supports collaborations and ideas that will transform the lives of individuals with, and/or at risk for, breast cancer and will significantly accelerate…
Basic mechanisms & biology
$35M totalDue Sep 30, 2026
Closing soonCancer & oncology
Closes in 6 daysDept. of Defense — CDMRP · HT942526RCRPCA
Summary: The fiscal year 2026 (FY26) Rare Cancers Research Program (RCRP) Concept Award (CA) supports highly innovative, untested, potentially groundbreaking novel concepts in rare cancers. Applications must describe how the new idea will be innovative and present as a novel…
$2.5M totalDue Sep 30, 2026
Closing soonSubstance use & addictionU54Clinical trial: Not allowed
Closes in 6 daysNational Institute on Drug Abuse (NIDA) · RFA-DA-27-015
The purpose of this notice of funding opportunity (NOFO) is to establish a Center that trains researchers in formal product development for new substance use disorder (SUD) pharmacotherapeutics and to advance the best concepts through initial experiments via technical and…
Therapeutics & drug discoveryTraining & career development
$3M totalDue Sep 30, 2026